2023
DOI: 10.1080/07391102.2023.2172456
|View full text |Cite
|
Sign up to set email alerts
|

Structure-based virtual screening of novel natural products as chalcone derivatives against SARS-CoV-2 M pro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 98 publications
0
1
0
Order By: Relevance
“…Then obtained pharmacophore was searched in the mentioned database using the MOE program (http://www.chemcomp.com), and only 1,336 of the 114,313 natural compounds in the library were extracted. Following a virtual screening using the PyRx program 42,43 , ve compounds were selected due to having the lowest binding energy (about -10 kcal/mol) and the hydrogen binding number to the active site compared to the standard ligand (empagli ozin). The pharmacokinetic properties of the six desired compounds were investigated along with the standard drug empagli ozin and three approved drugs (canagli ozin, dapagli ozin, and ertugli ozin) using programs the Schrödinger (Schrodinger Release 2021.2: QikProp, Schrodinger, LLC, New York, NY, 2021) and SwissADME [44][45][46][47] , that only two compounds (306 and 580) were in range for 95% known drugs.…”
Section: Methodsmentioning
confidence: 99%
“…Then obtained pharmacophore was searched in the mentioned database using the MOE program (http://www.chemcomp.com), and only 1,336 of the 114,313 natural compounds in the library were extracted. Following a virtual screening using the PyRx program 42,43 , ve compounds were selected due to having the lowest binding energy (about -10 kcal/mol) and the hydrogen binding number to the active site compared to the standard ligand (empagli ozin). The pharmacokinetic properties of the six desired compounds were investigated along with the standard drug empagli ozin and three approved drugs (canagli ozin, dapagli ozin, and ertugli ozin) using programs the Schrödinger (Schrodinger Release 2021.2: QikProp, Schrodinger, LLC, New York, NY, 2021) and SwissADME [44][45][46][47] , that only two compounds (306 and 580) were in range for 95% known drugs.…”
Section: Methodsmentioning
confidence: 99%
“…Small molecule compound screening has been widely used to identify inhibitors and medicines to be used in potential prevention and treatment strategies for various viral infections, such as severe acute respiratory syndrome coronavirus 2 [14,15], influenza A virus [16], dengue virus [17], and hepatitis C virus [18] infections.…”
Section: Sc Significantly Inhibits Prrsv Replicationmentioning
confidence: 99%